Insider Selling: Paysign (NASDAQ:PAYS) CEO Sells $767,000.00 in Stock

Paysign, Inc. (NASDAQ:PAYS) CEO Mark Newcomer sold 50,000 shares of Paysign stock in a transaction that occurred on Friday, October 9th. The stock was sold at an average price of $15.34, for a total value of $767,000.00. Following the transaction, the chief executive officer owned 9,113,002 shares of the company’s stock, valued at $139,793,450.68. This represents a 0.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Newcomer also recently made the following trade(s):

• On Thursday, August 6th, Mark Newcomer sold 150,000 shares of Paysign stock. The shares were sold at an average price of $11.88, for a total value of $1,782,000.00.
• On Wednesday, July 29th, Mark Newcomer sold 50,000 shares of Paysign stock. The shares were sold at an average price of $9.38, for a total value of $469,000.00.

Paysign Price Performance

Paysign stock traded down $0.32 during mid-day trading on Wednesday, hitting $15.16. 824,590 shares of the company were exchanged, compared to its average volume of 855,648. The business’s 50 day simple moving average is $13.34 and its two-hundred day simple moving average is $9.37. The company has a market capitalization of $855.93 million, a P/E ratio of 59.54 and a beta of 0.83. Paysign, Inc. has a 12-month low of $3.08 and a 12-month high of $15.62.

Paysign (NASDAQ:PAYS) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.06 by $0.05. Paysign had a return on equity of 30.13% and a net margin of 15.67%. The business had revenue of $28.25 million for the quarter, compared to the consensus estimate of $26.36 million. Paysign has set its FY 2026 guidance at 0.350-0.370 EPS and its Q3 2026 guidance at 0.090-0.100 EPS. Equities research analysts predict that Paysign, Inc. will post 0.58 earnings per share for the current year.

Hedge Funds Weigh In On Paysign

Institutional investors have recently added to or reduced their stakes in the business. Legal & General Group Plc purchased a new position in Paysign during the second quarter worth about $35,000. Caitong International Asset Management Co. Ltd grew its holdings in Paysign by 381.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 9,876 shares of the company’s stock valued at $51,000 after buying an additional 7,825 shares during the period. EFG International AG purchased a new stake in Paysign in the 2nd quarter valued at about $68,000. Quantbot Technologies LP acquired a new position in shares of Paysign during the 2nd quarter valued at about $97,000. Finally, The Manufacturers Life Insurance Company acquired a new position in shares of Paysign during the 2nd quarter valued at about $100,000. 25.89% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

PAYS has been the topic of a number of recent research reports. Weiss Ratings upgraded shares of Paysign from a “buy (b-)” rating to a “buy (b)” rating in a report on Thursday, October 8th. Lake Street Capital lifted their price target on shares of Paysign from $13.00 to $15.00 and gave the stock a “buy” rating in a report on Tuesday, September 15th. DA Davidson lifted their price target on shares of Paysign from $12.00 to $15.00 and gave the stock a “buy” rating in a report on Wednesday, September 30th. Wall Street Zen lowered shares of Paysign from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 16th. Finally, Barrington Research set a $15.00 target price on shares of Paysign in a research report on Tuesday, August 11th. Three investment analysts have rated the stock with a Buy rating. Based on data from MarketBeat, Paysign has an average rating of “Buy” and an average price target of $15.00.

About Paysign

Paysign, Inc (NASDAQ: PAYS) provides prepaid payment and financial technology solutions, with a focus on healthcare, pharmaceutical and other specialized markets. Its platform supports the issuance and management of prepaid cards, digital payments, account services and related payment-processing activities.

The company’s healthcare offerings include patient assistance and copay programs that help pharmaceutical manufacturers distribute financial support to eligible patients. Paysign also provides payment and card solutions for plasma collection centers, including programs used to compensate plasma donors.